1 |
B. Dubois, H. Hampel, H. H. Feldman, P. Scheltens, P. Aisen, S. Andrieu, H. Bakardjian, H. Benali, L. Bertram, K. Blennow, K. Broich, E. Cavedo, S. Crutch, J.-F. Dartigues, C. Duyckaerts, S. Epelbaum, G. B. Frisoni, S. Gauthier, R. Genthon, A. A. Gouw, M.-O. Habert, D. M. Holtzman, M. Kivipelto, S. Lista, J.-L. Molinuevo, S. E. O'Bryant, G. D. Rabinovici, C. Rowe, S. Salloway, L. S. Schneider, R. Sperling, M. Teichmann, M. C. Carrillo, J. Cummings, and J. C. R. Jack, Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria, Alzheimers Dement., 12, 292-323 (2016).
DOI
|
2 |
A. Accorroni, F. S. Giorgi, R. Donzelli, L. Lorenzini, C. Prontera, A. Saba, A. Vergallo, G. Tognoni, G. Siciliano, F. Baldacci, U. Bonuccelli, A. Clerico, and R. Zucchi, Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease, Endocrine, 55, 981-984 (2017).
DOI
|
3 |
L. Liu, N. Xia, and J. Wang, Potential applications of SPR in early diagnosis and progression of Alzheimer's disease, RSC Adv., 2, 2200-2204 (2012).
DOI
|
4 |
S. A. Park, J. H. Kim, H. J. Kim, T. E. Kim, Y.-J. Kim, D. H. Lee, J. H. Park, W. S. Chae, S. J. Yim, S. W. Seo, D. L. Na, and S. H. Choi, Preliminary study for a multicenter study of Alzheimer's disease cerebrospinal fluid biomarkers, Dement. Neurocogn. Disord., 12, 1-8 (2013).
DOI
|
5 |
J. M. Brockman, B. P. Nelson, and R. M. Corn, Surface plasmon resonance imaging measurements of ultrathin organic films, Annu. Rev. Phys. Chem., 51, 41-63 (2000).
DOI
|
6 |
K. M. Mayer and J. H. Hafner, Localized surface plasmon resonance sensors, Chem. Rev., 111, 3828-3857 (2011).
DOI
|
7 |
C. M. Cho, S. H. Kim, S. M. Yoon, Y. H. Ko, J. P. Jun, and J. H. Soung, Biomarker development for the diagnosis of Alzheimer's disease, Public Health Wkly. Rep., 8, 618-621 (2015).
|
8 |
M. Thambisetty, Y. An, A. Kinsey, D. Koka, M. Saleem, A. Guntert, M. Kraut, L. Ferrucci, C. Davatzikos, S. Lovestone, and S. M. Resnick, Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment, Neurolmage, 59, 212-217 (2012).
DOI
|
9 |
K. Hegnerova, M. Bockova, H. Vaisocherova, Z. Kristofikova, J. Ricny, D. Ripova, and J. Homola, Surface plasmon resonance biosensors for detection of Alzheimer disease biomarker, Sens. Actuators B, 139, 69-73 (2009).
DOI
|
10 |
L. Velayudhan, R. Killick, A. Hye, A. Kinsey, A. Guntert, S. Lynham, M. Ward, R. Leung, A. Lourdusamy, A. W. M. To, J. Powell, and S. Lovestone, Plasma transthyretin as a candidate marker for Alzheimer's disease, J. Alzheimers Dis., 28, 369-375 (2012).
DOI
|
11 |
S. Tonello, M. Serpelloni, N. F. Lopomo, G. Abate, D. L. Uberti, and E. Sardini, Screen-printed biosensors for the early detection of biomarkers related to Alzheimer disease: preliminary results, Procedia Eng., 168, 147-150 (2016).
DOI
|
12 |
H. R. Jang, A. W. Wark, S. H. Baek, B. H. Chung, and H. J. Lee, Ultrasensitive and ultrawide range detection of a cardiac biomarker on a surface plasmon resonance platform, Anal. Chem., 86, 814-819 (2014).
DOI
|
13 |
M. J. Kwon, J. Lee, A. W. Wark, and H. J. Lee, Nanoparticle-enhanced surface plasmon resonance detection of proteins at attomolar concentrations: comparing different nanoparticle shapes and sizes, Anal. Chem., 84, 1702-1707 (2012).
DOI
|
14 |
S. Zeng, D. Baillargeat, H.-P. Ho, and K.-T. Yong, Nanomaterials enhanced surface plasmon resonance for biological and chemical sensing applications, Chem. Soc. Rev., 43, 3426-3452 (2014).
DOI
|
15 |
H. Vaisocherova, V. M. Faca, A. D. Taylor, S. Hanash, and S. Jiang, Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera, Biosens. Bioelectron., 24, 2143-2148 (2009).
DOI
|
16 |
Y. Li, H. J. Lee, and R. M. Corn, Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging, Anal. Chem., 79, 1082-1088 (2007).
DOI
|
17 |
A. Bini, S. Centi, S. Tombelli, M. Minunni, and M. Mascini, Development of an optical RNA-based aptasensor for C-reactive protein, Anal. Bioanal. Chem., 90, 1077-1086 (2008).
|
18 |
J. Ladd, A. D. Taylor, M. Piliarik, J. Homola, and S. Jiang, Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging, Anal. Bioanal. Chem., 393, 1157-1163 (2009).
DOI
|
19 |
Z. Altintas, Y. Uludag, Y. Gurbuz, and I. E. Tothill, Surface plasmon resonance based immunosensor for the detection of the cancer biomarker carcinoembryonic antigen, Talanta, 86, 377-383 (2011).
DOI
|
20 |
Q. Zhao, R. Duan, J. Yuan, Y. Quan, H. Yang, and M. Xi, A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array, Int. J. Nanomed., 9, 1097-1104 (2014).
|
21 |
J.-F. Masson, Surface plasmon resonance clinical biosensors for medical diagnostics, ACS Sens., 2, 16-30 (2017).
DOI
|
22 |
J. Homola, Surface plasmon resonance sensors for detection of chemical and biological species, Chem. Rev., 108, 462-493 (2008).
DOI
|
23 |
A. J. Haes, W. P. Hall, L. Chang, W. L. Klein, and R. P. V. Duyne, A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer's disease, Nano Lett., 4, 1029-1034 (2004).
DOI
|
24 |
M. D. Sonawane and S. B. Nimse, Surface modification chemistries of materials used in diagnostic platforms with biomolecules, J. Chem., 2016, 1-19 (2016).
|
25 |
A. J. Haes, L. Chang, W. L. Klein, and R. P. V. Duyne, Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor, J. Am. Chem. Soc., 127, 2264-2271 (2005).
DOI
|
26 |
S. Shekhar, R. Kumar, N. Rai, V. Kumar, K. Singh, A. D. Upadhyay, M. Tripathi, S. Dwivedi, A. B. Dey, and S. Dey, Estimation of tau and phosphorylated tau181 in serum of Alzheimer's disease and mild cognitive impairment patients, PLoS ONE, 11, 1-10 (2016).
|
27 |
H. J. Lee, A. W. Wark, and R. M. Corn, Microarray methods for protein biomarker detection, Analyst, 133, 975-983 (2008).
DOI
|
28 |
G.-J. Ye, R. A. Oshins, F. N. Rouhani, M. L. Brantly, and J. D. Chulay, Development, validation and use of ELISA for antibodies to human alpha-1 antitrypsin, J. Immunol. Methods., 388, 18-24 (2013).
DOI
|
29 |
W. Zhou, P.-J. J. Huang, J. Ding, and J. Liu, Aptamer-based biosensors for biomedical diagnostics, Analyst, 139, 2627-2640 (2014).
DOI
|
30 |
L. Y. Yeo, H.-C. Chang, P. P. Y. Chan, and J. R. Friend, Microfluidic devices for bioapplications, Small, 7, 12-48 (2011).
DOI
|
31 |
H. Li, C. Ya, X. Wu, Z. Ye, and G. Li, Peptide-based electrochemical biosensor for amyloid soluble oligomer assay, Talanta, 93, 358-363 (2012).
DOI
|
32 |
C. Humpel, Identifying and validating biomarkers for Alzheimer's disease, Trends Biotechnol., 29, 26-32 (2011).
DOI
|
33 |
B. Olsson, R. Lautner, U. Andreasson, A. Ohrfelt, E. Portelius, M. Bjerke, M. Holtta, C. Rosen, C. Olsson, G. Strobel, E. Wu, K. Dakin, M. Petzold, K. Blennow, and H. Zetterberg, CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis, Lancet Neurol., 15, 673-684 (2016).
DOI
|
34 |
M. Thambisetty and S. Lovestone, Blood-based biomarkers of Alzheimer's disease: challenging but feasible, Biomark. Med., 4, 65-79 (2010).
DOI
|
35 |
K. Blennow and H. Hampel, CSF markers for incipient Alzheimer's disease, Lancet Neurol., 2, 605-613 (2003).
DOI
|
36 |
A. L. Baird, S. Westwood, and S. Lovestone, Blood-based proteomic biomarkers of Alzheimer's disease pathology, Front Neurol., 6, 1-16 (2015).
|
37 |
M. Ramakrishnan, K. K. Kandimalla, T. M. Wengenack, K. G. Howell, and J. F. Poduslo, Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid peptide-capturing and plaque-binding monoclonal antibodies, Biochemistry, 48, 10405-10415 (2009).
DOI
|
38 |
F. S. Diba, S. Kim, and H. J. Lee, Electrochemical immunoassay for amyloid-beta 1-42 peptide inbiological fluids interfacing with a gold nanoparticle modified carbonsurface, Catal. Today, https://doi.org/10.1016/j.cattod.2017.02.039.
DOI
|
39 |
V. P.-Grijalba, P. Pesini, I. Monleon, M. Boada, L. Tarraga, A. R.-Laza, P. M.-Lage, I. S.-Jose, and M. Sarasa, Several direct and calculated biomarkers from the amyloid- pool in blood are associated with an increased likelihood of suffering from mild cognitive impairment, J. Alzheimers Dis., 36, 211-219 (2013).
DOI
|
40 |
K. Henriksen, Y. Wang, M. G. Sorensen, N. Barascuk, J. Suhy, J. T. Pedersen, K. L. Duffin, R. A. Dean, M. Pajak, C. Christiansen, Q. Zheng, and M. A. Karsdal, An enzyme-generated fragment of tau measured in serum shows an inverse correlation to cognitive function, PLoS ONE, 8, 1-7 (2013).
|
41 |
Y. Liu, Q. Zhou, and A. Revzin, An aptasensor for electrochemical detection of tumor necrosis factor in human blood, Analyst, 138, 4321-4326 (2013).
DOI
|
42 |
M. Vestergaard, K. Kerman, M. Saito, N. Nagatani, Y. Takamura, and E. Tamiya, A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation, J. Am. Chem. Soc., 127, 11892-11893 (2005).
DOI
|
43 |
I. Abdulhalim, M. Zourob, and A. Lakhtakia, Surface plasmon resonance for biosensing: A mini-review, Electromagnetics, 28, 214-242 (2008).
DOI
|
44 |
T. Endo, K. Kerman, N. Nagatani, Y. Takamura, and E. Tamiya, Label-free detection of peptide nucleic acid-DNA hybridization using localized surface plasmon resonance based optical biosensor, Anal. Chem., 77, 6976-6984 (2005).
DOI
|
45 |
X. D. Hoa, A. G. Kirk, and M. Tabrizian, Towards intergrated and sensitive surface plasmon resonance biosensors: A review of recent progress, Biosens. Bioelectron., 23, 151-160 (2007).
DOI
|
46 |
S.-H. Jung, J.-W. Jung, I.-B. Suh, J. S. Yuk, W.-J. Kim, E. Y. Choi, Y.-M. Kim, and K.-S. Ha, Analysis of C-reactive protein on amide-linked n-hydroxysuccinimide-dextran arrays with a spectral surface plasmon resonance biosensor for serodiagnosis, Anal. Chem., 9, 5703-5710 (2007).
|
47 |
H. Englund, D. Sehlin, A.-S. Johansson, L. N. G. Nilsson, P. Gellerfors, S. Paulie, L. Lannfelt, and F. E. Pettersson, Sensitive ELISA detection of amyloid- protofibrils in biological samples, J. Neurochem., 103, 334-345 (2007).
|
48 |
R. J. Bateman, C. Xiong, T. L. S. Benzinger, A. M. Fagan, A. Goate, N. C. Fox, D. S. Marcus, N. J. Cairns, X. Xie, T. M. Blazey, D. M. Holtzman, A. Santacruz, V. Buckles, A. Oliver, K. Moulder, P. S. Aisen, B. Ghetti, W. E. Klunk, E. McDade, R. N. Martins, C. L. Masters, R. Mayeux, J. M. Ringman, M. N. Rossor, P. R. Schofield, R. A. Sperling, S. Salloway, and J. C. Morris, Clinical and biomarker changes in dominantly inherited Alzheimer's disease, N. Engl. J. Med., 367, 795-804 (2012).
DOI
|
49 |
J. Holger, Memory loss in Alzheimer's disease, Dialogues Clin. Neurosci., 15, 445-454 (2013).
|
50 |
A. Olaru, C. Bala, N. J.-Renault, and H. Y. A.-Enein, Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis, Crit. Rev. Anal. Chem., 45, 97-105 (2015).
DOI
|
51 |
S. Levy, M. McConville, G. A. Lazaro, and P. Averback, Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease, J. Clin. Lab. Anal., 21, 24-33 (2007).
DOI
|
52 |
F. S. Diba, S. Kim, and H. J. Lee, Amperometric bioaffinity sensing platform for avian influenza virus proteins with aptamer modified gold nanoparticles on carbon chips, Biosens. Bioelectron., 72, 355-361 (2015).
DOI
|
53 |
J. Homola, S. S. Yee, and G. Gauglitz, Susrface plasmon resonanace sensors: review, Sens. Actuators B, 54, 3-15 (1999).
DOI
|
54 |
R. M. Corn and S. C. Weibel, Fourier transform surface plasmon resonance in Handbook of vibrational spectroscopy, vol. 2, J. M. Chalmers and P. R. Griffiths (eds), John Wiley & Sons, Ltd, 1057-1064 (2006).
|
55 |
S. Kim, A. W. Wark, and H. J. Lee, Femtomolar detection of tau proteins in undiluted plasma using surface plasmon resonance, Anal. Chem., 88, 7793-7799 (2016).
DOI
|
56 |
S. Kim and H. J. Lee, Direct detection of : antitrypsin in serum samples using surface plasmon resonance with a new aptamer-antibody sandwich assay, Anal. Chem., 87, 7235-7240 (2015).
DOI
|